Business · 05/08/2003Updated: 10/17/2026 · 1 min read
FDA Withdraws Guidance on Clinical Evaluation of Analgesic Drugs
Summary
The Food and Drug Administration (FDA) is withdrawing its 1992 guidance on the clinical evaluation of analgesic drugs, citing outdated information, and plans to issue a revised draft for public comment in the future.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →